VAERS reports by lot

GSK Varicella/Shingles lot A5X5B: VAERS reports

48 VAERS reports list lot A5X5B as a GSK Varicella/Shingles vaccine, received between 2018-09-21 and 2019-07-03. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
48
Reports
8%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5128%
General / Systemic (non-local)4323%
Neurological2312%
Musculoskeletal158%
Dermatological (non-injection-site)148%
Allergic / Anaphylactic137%
Gastrointestinal127%
Cardiac / Cardiovascular74%
Psychiatric / Neuropsychiatric32%
Thrombotic / Hematological21%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Maryland6
California5
Georgia5
Pennsylvania4
Kansas4
Texas3
Ohio3
Colorado2
Indiana1
Minnesota1
Florida1
Oklahoma1

Reports by month received

2018-095
2018-1025
2018-1111
2019-012
2019-053
2019-061
2019-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.